Peripheral Vascular Devices – Market Insights – United States

The US PV device market will be driven by the continued rise in adoption of various endovascular treatment techniques and innovative product launches supported by favorable reimbursement programs, which will spur modest growth through 2032. However, the market is expected to face some challenge from push for cost-effective PV intervention, which has brought about adverse updates to reimbursement rates for major procedure types within the US PV intervention space.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in the US from 2019 through 2032.

The expansion of DES and DCB markets driven by positive clinical results will drive the US PV device market growth.

How has the adoption of DES and DCB in the US market responded to the latest findings from the clinical trials and the FDA ruling on the safety concerns raised for paclitaxel-based devices?

What are the main findings from the completed clinical trials and target findings from ongoing clinical trials for DESs and DCBs that will contribute to the continued rise in uptake of DES and DCB?

What impact will the entrance of new DCBs have on the PTA balloon catheter market?

Innovative new devices for endovascular treatment of BTK lesions will bolster the PV device market going forward.

What are the device types and technological innovations being evaluated to address unique challenges of treating BTK lesions?

Which competitors are standing to gain market with the new devices, and how will it shape the market going forward?

Varying changes to the reimbursement rates by site of service and procedure type will influence the PV device uptake.

What new reimbursement updates released by the CMS will have an impact on the PV device uptake?

How have recent reimbursement policies influenced the site-of-service penetration for different PV procedure types?

Several key players in the PV device market have expanded their presence in the US market through acquisition and partnerships.

Which key players in the PV device market were involved in the acquisition and partnership, and how will these developments impact the key players’ standing in the future?

How will the key players that completed the acquisition or partnership adjust their marketing strategies to optimally utilize their expanded PV device portfolio?

What impact will the modified marketing strategies have on the PV device availability and cost?

Table of contents

Peripheral Vascular Devices - Market Insights - United States

Lewis Joo

Lewis Joo is a senior analyst on the Cardiovascular Medtech Insights team at Clarivate, focusing on devices for aortic repair, deep venous disease, dialysis access, and peripheral vascular treatment. Lewis holds a Master’s degree in Medical Biophysics from the University of Toronto. Prior to his current position, Lewis worked at the Sunnybrook Health Sciences Center, working on preclinical imaging research projects on neurodegeneration.

Contact sales Login to access report

Back to all Medtech Insights reports